C
Chandra Bhagat Pharma Ltd
BSE:542934
Chandra Bhagat Pharma Ltd
BSE:542934
Price:
34.5
INR
4.45%
Market Closed
Market Cap:
₹260.5m
Relative Value
There is not enough data to reliably calculate the relative value of CBPL.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CBPL
Relative Value
Base Case
Not Available
Multiples Across Competitors
CBPL Competitors Multiples
Chandra Bhagat Pharma Ltd Competitors
Chandra Bhagat Pharma Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
C
|
Chandra Bhagat Pharma Ltd
BSE:542934
|
260.3m INR | 0.2 | 16.5 | -7.6 | -6.1 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
113.2B USD | 0.3 | 26.1 | 18.3 | 20.6 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
65B USD | 0.2 | 40 | 14.1 | 17.8 | |
| US |
|
Cencora Inc
NYSE:COR
|
63.3B USD | 0.2 | 39 | 13.8 | 17.4 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50B USD | 0.2 | 30.1 | 14.5 | 18.9 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.8B AUD | 2.6 | 33.4 | 24.9 | 24.9 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.7B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.2B CNY | 1.5 | 17.1 | 13.2 | 13.2 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.5B USD | 0.6 | 21.3 | 10.4 | 14.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.6B HKD | 0.1 | 8.5 | 1.5 | 1.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
